jRCT ロゴ

臨床研究等提出・公開システム

Top

Japanese

Mar. 19, 2009

Dec. 17, 2018

jRCT2080220697

Phase III study of SUN11031 for eating disorders

version:
date:

DAIICHI SANKYO Co.,Ltd.

http://www.daiichisankyo.co.jp/contact/clinical/index.html

Interventional

3

Diagnosis of anorexia nervosa (restricting type) or eating disorders not otherwise specified according to the DSM-IV diagnostic criteria.

15age old over
No limit

Both

Eating disorders (anorexia nervosa and eating disorders not otherwise specified)

investigational material(s)
Generic name etc : SUN11031
INN of investigational material :
Therapeutic category code : 119 Other agents affecting central nervous system
Dosage and Administration for Investigational material : Subjects will receive 0 or 2.0 ug/kg of SUN11031 intravenously twice a day (before breakfast, before supper) for 20 days.

DAIICHISANKYO Co.,Ltd.

JapicCTI-090723

History of Changes

No Publication date
9 Dec. 17, 2018 (this page) Changes
8 May. 15, 2012 Detail Changes
7 May. 15, 2012 Detail Changes
6 May. 11, 2011 Detail Changes
5 May. 11, 2011 Detail Changes
4 Jan. 27, 2011 Detail Changes
3 April. 19, 2010 Detail Changes
2 April. 13, 2010 Detail Changes
1 Mar. 19, 2009 Detail